Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 22.
doi: 10.1007/s11357-025-01660-3. Online ahead of print.

Sex differences in body mass index and waist circumference trajectories and dementia risk: the HUNT4 70+ study

Affiliations

Sex differences in body mass index and waist circumference trajectories and dementia risk: the HUNT4 70+ study

Ekaterina Zotcheva et al. Geroscience. .

Erratum in

Abstract

We examined associations between body mass index (BMI), waist circumference (WC), and dementia risk, and differences in BMI and WC trajectories before dementia diagnosis. We included 9,739 participants (54% women) aged 70+ from the Trøndelag Health Study (HUNT4 70+). BMI was measured four times (1984-2019) and WC three times (1995-2019). Dementia diagnoses were clinically assessed at HUNT4 70+ . Women and men with dementia had higher midlife BMI and WC than those without dementia. These differences diminished closer to diagnosis, especially in women. Midlife obesity in both sexes and midlife overweight, high WC, and overweight/obesity with high WC in men were linked to higher dementia risk. Lower dementia risk was observed with late-life overweight for both sexes, late-life high WC in women, late-life overweight/obesity with normal WC in men or high WC in women. Adiposity measures and their changes influence dementia risk differently in women and men.

Keywords: Adiposity; Anthropometric measures; Cognitive impairment; Life-course perspective; Population-based study.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest: EZ, BHS, VS, KD, SK, GL and ASM declare no conflicts of interest. GS has participated in Advisory Board meetings for Roche, Eli-Lilly and Eisai regarding disease-modifying drugs for Alzheimer’s disease. GS has received honoraria for delivering lectures at symposia sponsored by Eisai and Eli-Lilly.

References

    1. GBD. Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2019;2022(7):e105–25. https://doi.org/10.1016/s2468-2667(21)00249-8 . - DOI
    1. Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572–628. https://doi.org/10.1016/s0140-6736(24)01296-0 . - DOI - PubMed
    1. Rosenau C, Köhler S, Soons LM, Anstey KJ, Brayne C, Brodaty H, et al. Umbrella review and Delphi study on modifiable factors for dementia risk reduction. Alzheimers Dement. 2024;20:2223–39. https://doi.org/10.1002/alz.13577 . - DOI - PubMed
    1. Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, et al. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement: Diagn Assess Dis Monit. 2017;8:165–78. https://doi.org/10.1016/j.dadm.2017.05.007 . - DOI
    1. Qu Y, Hu HY, Ou YN, Shen XN, Xu W, Wang ZT, et al. Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev. 2020;115:189–98. https://doi.org/10.1016/j.neubiorev.2020.05.012 . - DOI - PubMed

LinkOut - more resources